ESR1 and breast cancer: Cytotoxic effects of benzopyran based platinum II complexes have been reported earlier in ER- negative breast cancer cells but their mechanism of action have not been explored in these cells [23].We hypothesized that compound may interfere with various signaling mechanisms and inhibit growth in breast cancer cells which do not express ER.